MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.13560

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.

Sanchez Erlan, Wilkinson Tim, Coughlan Gillian, Mirza Saira, Baril Andrée-Ann, Ramirez Joel, Binns Malcolm A, Black Sandra E, Borrie Michael, Dilliott Allison A, Dixon Roger A, Dowlatshahi Dar, Farhan Sali, Finger Elizabeth, Fischer Corinne E, Frank Andrew, Freedman Morris, Goncalves Rafaella A, Grimes David A, Hassan Ayman, Hegele Robert A, Kumar Sanjeev, Lang Anthony E, Marras Connie, McLaughlin Paula M, Orange Joseph B, Pasternak Stephen H, Pollock Bruce G, Rajji Tarek K, Roberts Angela C, Robinson John F, Rogaeva Ekaterina, Sahlas Demetrios J, Saposnik Gustavo, Strong Michael J, Swartz Richard H, Tang-Wai David F, Tartaglia Maria Carmela, Troyer Angela K, Kvartsberg Hlin, Zetterberg Henrik, Munoz Douglas P, ONDRI Investigators, Masellis Mario

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

We investigated whether novel plasma biomarkers are associated with cognition, cognitive decline, and functional independence in activities of daily living across and within neurodegenerative diseases.

METHODS

Glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), phosphorylated tau (p-tau)181 and amyloid beta (Aβ)42/40 were measured using ultra-sensitive Simoa immunoassays in 44 healthy controls and 480 participants diagnosed with Alzheimer's disease/mild cognitive impairment (AD/MCI), Parkinson's disease (PD), frontotemporal dementia (FTD) spectrum disorders, or cerebrovascular disease (CVD).

RESULTS

GFAP, NfL, and/or p-tau181 were elevated among all diseases compared to controls, and were broadly associated with worse baseline cognitive performance, greater cognitive decline, and/or lower functional independence. While GFAP, NfL, and p-tau181 were highly predictive across diseases, p-tau181 was more specific to the AD/MCI cohort. Sparse associations were found in the FTD and CVD cohorts and for Aβ42/40 .

DISCUSSION: GFAP, NfL, and p-tau181 are valuable predictors of cognition and function across common neurodegenerative diseases, and may be useful in specialized clinics and clinical trials.

Для цитирования: Sanchez Erlan, Wilkinson Tim, Coughlan Gillian, Mirza Saira, Baril Andrée-Ann, Ramirez Joel, Binns Malcolm A, Black Sandra E, Borrie Michael, Dilliott Allison A, Dixon Roger A, Dowlatshahi Dar, Farhan Sali, Finger Elizabeth, Fischer Corinne E, Frank Andrew, Freedman Morris, Goncalves Rafaella A, Grimes David A, Hassan Ayman, Hegele Robert A, Kumar Sanjeev, Lang Anthony E, Marras Connie, McLaughlin Paula M, Orange Joseph B, Pasternak Stephen H, Pollock Bruce G, Rajji Tarek K, Roberts Angela C, Robinson John F, Rogaeva Ekaterina, Sahlas Demetrios J, Saposnik Gustavo, Strong Michael J, Swartz Richard H, Tang-Wai David F, Tartaglia Maria Carmela, Troyer Angela K, Kvartsberg Hlin, Zetterberg Henrik, Munoz Douglas P, ONDRI Investigators, Masellis Mario. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023. DOI: 10.1002/alz.13560.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.